Blog Archives

Ivosidenib (Tibsovo) for AML-patients with IDH1-mutations

July 22, 2018 – The American Food and Drug Administration (FDA) just approved Ivosidenib (Tibsovo) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation in the IDH1 gene.  

Read more ›

Tags: , , , , , , , , , , , , , ,

From diarrhea to long QT: Serious heart problems with high doses of Loperamide (Imodium) from abuse and misuse

June 08, 2016 – In the United States, Loperamide (Imodium) is approved to help control symptoms of diarrhea, including Travelers’ Diarrhea. The maximum approved daily dose for adults is 8 mg per day for the Over-the-Counter (OTC)-form and 16 mg per day for prescription form.

Read more ›

Tags: , , , , , ,

thasso: community

thasso: conditions

thasso post: magazine

View my Flipboard Magazine.

thasso: follow us

thasso: chat

You must be a registered user to participate in this chat.

thasso: tweets

thasso: categories

thasso: archives

Top